Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

Press Release/Announcement

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; June 13, 2011.

This notice raises awareness of a two look-alike/sound-alike drugs, one an antipsychotic medication and the other a dopamine agonist.

Free full text

Related Resources From the Same Author(s)

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

March 12, 2010

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

September 29, 2010

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

Related Resources

Medication guides: patient medication information. A proposed rule by the Food and Drug Administration.

June 28, 2023

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

September 30, 2015

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

March 22, 2010

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

See More About The Topic

Health Care Providers

Risk Managers

Quality and Safety Professionals

Patients

Pharmacy

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users